Treatment of condyloma acuminatum
1. Cryotherapy: Using freezing method can make the condyloma acuminatum freeze, forming a local high degree of edema of the tissue, thereby destroying the wart body. For the treatment of condyloma acuminatum in women, the biggest benefit of cryotherapy is to leave no traces locally, and the cure rate is about 70%. Women’s treatment of genital warts is suitable for patients with warts that are not too large or extensive. Patients with this method are more painful and have a higher recurrence rate. Treatment can be carried out 1-2 times, with an interval of 1 week.
2. Electrocautery: Cauterize with high-frequency power or electric needle. It is characterized by simple operation and quick results. The treatment of condyloma acuminatum in women can directly remove and dry the wart body, and the treatment is more thorough. It can be used for the treatment of any condyloma acuminatum, but the technical requirements of the surgeon are relatively high. Excessive or insufficient cauterization is harmful. In the treatment of condyloma acuminatum in women, due to the slow healing of the skin surface after electrocautery, it is necessary to prevent infection after treatment.
3. Surgical resection: Condyloma acuminatum generally does not advocate surgical resection, because after surgical treatment, condyloma acuminatum is easy to relapse, making the treatment fail. Women’s treatment of genital warts, but for larger warts with pedicles, if there are patients with genital warts that grow too quickly, or as large as cauliflower, other methods of treatment are very difficult, and surgical treatment may be considered. In order to prevent relapse, postoperatively cooperate with other treatments.
4. Topical topical medicine: 10% -25% podophyllum tincture or 0.5 potentol toxin for external use, female treatment of genital warts twice a day, the latter is low in concentration, local irritation is small, poisoned after absorption There is very little possibility. This medicine is the first choice for the treatment of this disease abroad, and it is usually cured once. Women’s treatment of condyloma acuminatum has the disadvantage that it is very destructive to tissues and improper use can cause local ulcers; toxicity is also large. After poisoning, nausea, intestinal obstruction, leukopenia and thrombocytopenia, urinary closure or oliguria must be used with caution. For women with condyloma acuminatum, if the above reaction is found, the drug should be stopped immediately. This medicine has teratogenic effects and is contraindicated in pregnant women.
It can also be used with 3% peptide butylamine cream, for external use, twice a day. This medicine is less irritating and has better curative effect. For women with condyloma acuminatum, or 0.25% herpes net ointment, twice a day, external application
Of course, the treatment methods for different groups of people are also different, such as the treatment of women during pregnancy. This treatment method is special. The treatment of condyloma acuminatum for women should be gradually cured based on the control of the disease. Can not use large doses of drug treatment, otherwise it will cause a certain impact on the body.
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.
Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.
Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.
Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.
These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.
Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.
